Increased Risk of Transfusion Reactions in Postpartum Blood Transfusions Transfusion reactions occur in 0.15% to 3.7% of all transfusions and can range from mild fevers to severe, life-threatening reactions…. August 28, 2019
Transfusion Important for Treatment of Warm Autoimmune Hemolytic Anemia Warm autoimmune hemolytic anemia (WAHA) affects 1 to 3 per 100,000 individuals per year and is the most common type… August 22, 2019
Red Blood Cells Donated by Smokers Associated with Lower Increments Many recent studies have investigated the safety of blood according to donor demographics (e.g. age, sex, genetic polymorphisms) and blood… August 14, 2019
Transfusion of African Children with Severe Anemia In order to better understand when to transfuse children with severe anemia (hemoglobin less than 6 g per deciliter) researchers… August 7, 2019
A New Class of Drug to Treat Anemia in Patients with Chronic Kidney Disease Erythropoietin and iron supplements have been used for 30 years to treat anemia in patients with chronic kidney disease, but… July 31, 2019
WHO Declares Ebola Outbreak in the Democratic Republic of the Congo an International Emergency The World Health Organization (WHO) has declared the Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo… July 25, 2019
RBC Alloimmunization is a Predictor of HLA Alloimmunization Alloantibodies to the human leukocyte antigens (HLA) or red blood cells (RBCs) can develop after exposure to alloantigens such as… July 17, 2019
The Role of Osteopontin in Murine TRALI Osteopontin (OPN) is a proinflammatory, multifunctional protein with both physiological and pathological roles. Since OPN attracts neutrophils, which are involved… July 11, 2019
Is there a Role for Liberal Transfusion Strategies? Based on data from more than 30 clinical trials, the AABB clinical practice guidelines recommend restrictive transfusion thresholds for hemodynamically… July 5, 2019
Experimental Drug Voxelotor for Treatment of Patients with Sickle Cell Disease Results from a multicenter, randomized, clinical trial suggests that voxelotor, which inhibits sickle hemoglobin (HbS) polymerization, may be beneficial for… July 3, 2019
